JPRN-UMIN000028770已完成未知
The intravitreal injection of Bevacizumab for retinopathy of prematurity - The intravitreal injection of Bevacizumab for ROP
Department of Ophthalmology, Shiga University of Medical Science0 个研究点目标入组 24 人开始时间: 2017年8月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The patients with systemic risk factors
研究者
相似试验
已完成
不适用
Intravitreal bevacizumab injection for intraocular neovascularization in childreRetinopathy of prematurityJPRN-UMIN000014316Kansai Medical University15
已完成
不适用
Intravitreal bevacizumab treatment for severe retinopathy of prematuritysevere retinopathy of prematurityJPRN-UMIN000018122The Jikei University School of Medicine Department of Ophthalmology6
尚未招募
不适用
Intravitreal Bevaxizumab injection for intraocular neovasculalization in childreretinopathy of prematurityJPRN-UMIN000007465Tokushima university hospital10
尚未招募
2 期
Role of subconjunctival injection of Bevacizumab (Anti VEGF) for Corneal Neovascularisation,after cornea TransplantCTRI/2021/10/037416SNMedical College
已完成
3 期
Effect of diclofenac eye drop and Bevacizumab and Triamcinolone in preventing part of the retina edemaDiabetic retinopathyDiabetic retinopathy.IRCT2017050833875N1Vice chancellor For Research Of Ahvaz Jundishapur University of Medical Sciences45